PP
KERX

PDT Partners’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

PDT Partners’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-41,912
Closed -$418K – 1728
2015
Q2 		$418K Buy
+41,912
New +$449K 0.01% 1032
2015
Q1 		– Sell
-164,350
Closed -$2.33M – 1470
2014
Q4 		$2.33M Buy
164,350
+130,781
+390% +$2.03M 0.22% 102
2014
Q3 		$462K Buy
+33,569
New +$514K 0.01% 965

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

PDT Partners's KERX Position: Q3 2015 in Review

PDT Partners sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2015, closing a stake of 41,912 shares — an estimated $418K sold.

PDT Partners first reported a position in KERX in Q3 2014 and held it in 3 quarters. The position peaked at $2.33M in Q4 2014. 138 funds tracked by Wall St. Rank hold KERX as of Q3 2015.

  • PDT Partners reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • PDT Partners sold 41,912 Keryx Biopharmaceuticals Inc shares in Q3 2015, an estimated $418K.
  • PDT Partners first reported a position in Keryx Biopharmaceuticals Inc in Q3 2014 and held it in 3 quarters.
  • PDT Partners's Keryx Biopharmaceuticals Inc position peaked at $2.33M in Q4 2014.
  • 138 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2015.

Based on PDT Partners's 13F filing for Q3 2015, filed 16 Nov 2015.